Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bakker JL"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Moes DJAR; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. D.J.A.R.Moes@lumc.nl., Hendrikx JJMA; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute (NKI-AVL), Amsterdam, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands., Bakker JL; Department of Medical Oncology, Amphia Hospital, Breda, The Netherlands., Dezentjé VO; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Rouw N; Department of Clinical Pharmacy, Amphia Hospital, Breda, The Netherlands.; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., van Erp NP; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands., Smit EF; Department of Pulmonology, Leiden University Medical Centre, Leiden, The Netherlands., van den Heuvel MM; Department of Pulmonology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Munnink THO; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands., van Kats M; Division of Medical Oncology, Department of Internal Medicine M. van Kats, Maastricht University Medical Center Maastricht, Maastricht, The Netherlands., Croes S; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center Maastricht, Maastricht, The Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Zwaveling J; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Ter Heine R; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Targeted oncology [Target Oncol] 2024 Sep; Vol. 19 (5), pp. 789-796. Date of Electronic Publication: 2024 Jun 18.
Autor:
Bakker JL; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: h.verheul@vumc.nl., Wever K; Department of Internal Medicine, Spaarne Ziekenhuis, Hoofddorp, The Netherlands., van Waesberghe JH; Department of Radiology, VU University Medical Center, Amsterdam, The Netherlands., Beeker A; Department of Internal Medicine, Spaarne Ziekenhuis, Hoofddorp, The Netherlands., Meijers-Heijboer H; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands., Konings IR; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands., Verheul HM; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Publikováno v:
Cancer epidemiology [Cancer Epidemiol] 2015 Dec; Vol. 39 (6), pp. 848-53. Date of Electronic Publication: 2015 Nov 09.
Autor:
Bakker JL; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands., Thirthagiri E, van Mil SE, Adank MA, Ikeda H, Verheul HM, Meijers-Heijboer H, de Winter JP, Sharan SK, Waisfisz Q
Publikováno v:
Human mutation [Hum Mutat] 2014 Apr; Vol. 35 (4), pp. 442-6. Date of Electronic Publication: 2014 Feb 15.
Autor:
Bakker JL; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands; Department of Clinical Genetics, Section Oncogenetics, VU University Medical Center, Amsterdam, The Netherlands., Meijers-Heijboer H, Verheul H
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2013 Oct 05; Vol. 717 (1-3), pp. 36-9. Date of Electronic Publication: 2013 Mar 30.
Autor:
Bakker JL; Department of Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands., van Mil SE, Crossan G, Sabbaghian N, De Leeneer K, Poppe B, Adank M, Gille H, Verheul H, Meijers-Heijboer H, de Winter JP, Claes K, Tischkowitz M, Waisfisz Q
Publikováno v:
Human mutation [Hum Mutat] 2013 Jan; Vol. 34 (1), pp. 70-3. Date of Electronic Publication: 2012 Oct 11.
Autor:
Peng M; Cancer Center, Institute of Molecular Medicine and Genetics, Medical College of Georgia, Georgia Regents University, Augusta, GA, USA., Bakker JL, Dicioccio RA, Gille JJ, Zhao H, Odunsi K, Sucheston L, Jaafar L, Mivechi NF, Waisfisz Q, Ko L
Publikováno v:
Genes & cancer [Genes Cancer] 2013 Jan; Vol. 4 (1-2), pp. 15-25.